BioLife Solutions, Inc. stock is up 20.84% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45.45% of the previous 21 December’s closed higher than November.
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for cell and gene therapy industry. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor.